cas 40794-04-5|| where to buy 4-Chloro-2-methoxy-1-methylbenzene

Product Name:4-Chloro-2-methoxy-1-methylbenzene

IUPAC Name:4-chloro-2-methoxy-1-methylbenzene

Packing Unit	Available Stock	Price($)
CM283380-5g	in stock	ȃȃ
CM283380-10g	in stock	ǪǙľ
CM283380-25g	in stock	ǪůĲ
CM283380-100g	in stock	ȃǪŹ

For R&D use only.

Inquiry Form

Chemical Name

CAS Number

Quantity*

Required Specifications*
(Assay %, Material Grade etc.)

Contact Name*

Contact Email*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 40794-04-5 regularly via the above email.

Additional Notes

Verification code*

refresh

: CAS NO:40794-04-5; Molecular Formula:C8H9ClO; Melting Point:-; Smiles Code:CC1=CC=C(Cl)C=C1OC; Density:

: Catalog Number:CM283380; Molecular Weight:156.61; Boiling Point:204°C at 760 mmHg; MDL No:MFCD07368289; Storage:Store at 2-8°C.

: Crinecerfont; The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.